8-K 1 cli8k012507.txt CURRENT REPORT DATED JANUARY 25, 2007 ============================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 8-K _________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2007 CARRINGTON LABORATORIES, INC. (Exact name of Registrant as specified in its charter) Texas 0-11997 75-1435663 ------------------------------- ---------- ---------------- (State or other jurisdiction of Commission (I.R.S. Employer incorporation or organization) File Number Identification No.) 2001 Walnut Hill Lane Irving, Texas 75038 ---------------------------------------- ---------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (972) 518-1300 Not applicable ---------------------------------------------------- (Former name, former address and former fiscal year, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ============================================================================ Item 1.01. Entry Into A Material Definitive Agreement On January 25, 2007, Carrington Laboratories, Inc. ("Carrington") entered into a Trademark License and Supply Agreement ("Agreement") with Mannatech, Incorporated ("Mannatech"), effective January 1, 2007. The initial term of the Agreement expires on December 31, 2009. Under the terms of the Agreement, Mannatech has agreed to purchase from Carrington certain minimum monthly quantities of Manapol[R] powder. The Agreement also grants Mannatech a non-exclusive, royalty free right to use the Manapol[R] trademark, in connection with Mannatech's labeling, advertising and sale of its products. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. EXHIBIT NUMBER DESCRIPTION ------ ----------- 99.1* Trademark License and Supply Agreement dated January 25, 2007, between Carrington Laboratories, Inc. and Mannatech, Incorporated. __________________ * Application has been made to the Securities and Exchange Commission for confidential treatment of certain provisions of this exhibit. Omitted material for which confidential treatment has been requested has been filed separately with the Securities and Exchange Commission. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CARRINGTON LABORATORIES, INC. Date: January 31, 2007 By: /s/ Carlton E. Turner ------------------------------------- Carlton E. Turner, Ph.D., D.Sc. President and Chief Executive Officer INDEX TO EXHIBITS Exhibit Number Description ------ ----------- 99.1* Trademark License and Supply Agreement dated January 25, 2007, between Carrington Laboratories, Inc. and Mannatech, Incorporated. __________________ * Application has been made to the Securities and Exchange Commission for confidential treatment of certain provisions of this exhibit. Omitted material for which confidential treatment has been requested has been filed separately with the Securities and Exchange Commission.